The publisher's Medical Devices sector report, “Extracorporeal Membrane Oxygenation Devices - Medical Devices Pipeline Product Landscape, 2021' provides comprehensive information about the Extracorporeal Membrane Oxygenation Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Patients that have developed the inability to properly oxygenate their blood, due to complications of the lung, heart, or both, are candidates to receive extracorporeal membrane oxygenation (ECMO).
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Patients that have developed the inability to properly oxygenate their blood, due to complications of the lung, heart, or both, are candidates to receive extracorporeal membrane oxygenation (ECMO).
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Extracorporeal Membrane Oxygenation Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Extracorporeal Membrane Oxygenation Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Extracorporeal Membrane Oxygenation Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Extracorporeal Membrane Oxygenation Devices - Pipeline Products under Development by Companies
5 Extracorporeal Membrane Oxygenation Devices Companies and Product Overview
6 Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Boundless Science LLC
- CVD Equipment Corp
- Elsius Biomedical Inc
- Ension, Inc.
- FreeFlow Medical Devices LLC
- Haemair Ltd
- Hemovent GmbH
- Inspira Technologies Oxy Bhn Ltd
- Jiangsu STMed Technologies Co
- LivaNova PLC
- MC3 Inc
- MedArray Inc.
- Nipro Corp
- Pavmed Inc
- Qfluidics Inc
- Shandong University
- The Charles Stark Draper Laboratory Inc
- Thoratec LLC
- University of California San Francisco
- Xenios AG
